FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386838521> ?p ?o ?g. }

• W4386838521 endingPage "6504" @default.
• W4386838521 startingPage "6495" @default.
• W4386838521 abstract "Chikungunya virus (CHIKV) is an alphavirus transmitted by mosquitos that causes a debilitating disease characterized by fever and long-lasting polyarthralgia. To date, no vaccine has been licensed, but multiple vaccine candidates are under evaluation in clinical trials. One of these vaccines is based on a measles virus vector encoding for the CHIKV structural genes C, E3, E2, 6K, and E1 (MV-CHIK), which proved safe in phase I and II clinical trials and elicited CHIKV-specific antibody responses in adult measles seropositive vaccine recipients. Here, we predicted T-cell epitopes in the CHIKV structural genes and investigated whether MV-CHIK vaccination induced CHIKV-specific CD4+ and/or CD8+ T-cell responses. Immune-dominant regions containing multiple epitopes in silico predicted to bind to HLA class II molecules were found for four of the five structural proteins, while no such regions were predicted for HLA class I. Experimentally, CHIKV-specific CD4+ T-cells were detected in six out of twelve participants after a single MV-CHIK vaccination and more robust responses were found 4 weeks after two vaccinations (ten out of twelve participants). T-cells were mainly directed against the three large structural proteins C, E2 and E1. Next, we sorted and expanded CHIKV-specific T cell clones (TCC) and identified human CHIKV T-cell epitopes by deconvolution. Interestingly, eight out of nine CD4+ TCC recognized an epitope in accordance with the in silico prediction. CHIKV-specific CD8+ T-cells induced by MV-CHIK vaccination were inconsistently detected. Our data show that the MV-CHIK vector vaccine induced a functional transgene-specific CD4+ T cell response which, together with the evidence of neutralizing antibodies as correlate of protection for CHIKV, makes MV-CHIK a promising vaccine candidate in the prevention of chikungunya." @default.
• W4386838521 created "2023-09-19" @default.
• W4386838521 creator A5010966529 @default.
• W4386838521 creator A5012707353 @default.
• W4386838521 creator A5026070939 @default.
• W4386838521 creator A5031207622 @default.
• W4386838521 creator A5035418449 @default.
• W4386838521 creator A5047066427 @default.
• W4386838521 creator A5048751083 @default.
• W4386838521 creator A5058614583 @default.
• W4386838521 creator A5071431150 @default.
• W4386838521 creator A5073178223 @default.
• W4386838521 date "2023-10-01" @default.
• W4386838521 modified "2023-10-12" @default.
• W4386838521 title "A measles virus-based vaccine induces robust chikungunya virus-specific CD4+ T-cell responses in a phase II clinical trial" @default.
• W4386838521 cites W196757896 @default.
• W4386838521 cites W1971143002 @default.
• W4386838521 cites W1983931696 @default.
• W4386838521 cites W1987914621 @default.
• W4386838521 cites W2031844355 @default.
• W4386838521 cites W2033096879 @default.
• W4386838521 cites W2046391048 @default.
• W4386838521 cites W2063364341 @default.
• W4386838521 cites W2064659419 @default.
• W4386838521 cites W2070608209 @default.
• W4386838521 cites W2072756799 @default.
• W4386838521 cites W2075200165 @default.
• W4386838521 cites W2091260342 @default.
• W4386838521 cites W2094084149 @default.
• W4386838521 cites W2096525106 @default.
• W4386838521 cites W2121966467 @default.
• W4386838521 cites W2136631930 @default.
• W4386838521 cites W2145610587 @default.
• W4386838521 cites W2325831581 @default.
• W4386838521 cites W2511148504 @default.
• W4386838521 cites W2564235626 @default.
• W4386838521 cites W2587369815 @default.
• W4386838521 cites W2597732596 @default.
• W4386838521 cites W268526039 @default.
• W4386838521 cites W2749766789 @default.
• W4386838521 cites W2767051043 @default.
• W4386838521 cites W2771338911 @default.
• W4386838521 cites W2802009726 @default.
• W4386838521 cites W2808716522 @default.
• W4386838521 cites W2900296786 @default.
• W4386838521 cites W2911184439 @default.
• W4386838521 cites W2943793383 @default.
• W4386838521 cites W2954611991 @default.
• W4386838521 cites W3011488280 @default.
• W4386838521 cites W3014720962 @default.
• W4386838521 cites W3037718428 @default.
• W4386838521 cites W3184246351 @default.
• W4386838521 cites W3203139340 @default.
• W4386838521 cites W4306254948 @default.
• W4386838521 cites W4306803604 @default.
• W4386838521 cites W4309169895 @default.
• W4386838521 cites W4323923714 @default.
• W4386838521 cites W4360853935 @default.
• W4386838521 doi "https://doi.org/10.1016/j.vaccine.2023.09.022" @default.
• W4386838521 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37726181" @default.
• W4386838521 hasPublicationYear "2023" @default.
• W4386838521 type Work @default.
• W4386838521 citedByCount "0" @default.
• W4386838521 crossrefType "journal-article" @default.
• W4386838521 hasAuthorship W4386838521A5010966529 @default.
• W4386838521 hasAuthorship W4386838521A5012707353 @default.
• W4386838521 hasAuthorship W4386838521A5026070939 @default.
• W4386838521 hasAuthorship W4386838521A5031207622 @default.
• W4386838521 hasAuthorship W4386838521A5035418449 @default.
• W4386838521 hasAuthorship W4386838521A5047066427 @default.
• W4386838521 hasAuthorship W4386838521A5048751083 @default.
• W4386838521 hasAuthorship W4386838521A5058614583 @default.
• W4386838521 hasAuthorship W4386838521A5071431150 @default.
• W4386838521 hasAuthorship W4386838521A5073178223 @default.
• W4386838521 hasBestOaLocation W43868385211 @default.
• W4386838521 hasConcept C159047783 @default.
• W4386838521 hasConcept C159654299 @default.
• W4386838521 hasConcept C167672396 @default.
• W4386838521 hasConcept C195616568 @default.
• W4386838521 hasConcept C203014093 @default.
• W4386838521 hasConcept C22070199 @default.
• W4386838521 hasConcept C2522874641 @default.
• W4386838521 hasConcept C2776438120 @default.
• W4386838521 hasConcept C2777474056 @default.
• W4386838521 hasConcept C2778199166 @default.
• W4386838521 hasConcept C2781273456 @default.
• W4386838521 hasConcept C86803240 @default.
• W4386838521 hasConcept C8891405 @default.
• W4386838521 hasConceptScore W4386838521C159047783 @default.
• W4386838521 hasConceptScore W4386838521C159654299 @default.
• W4386838521 hasConceptScore W4386838521C167672396 @default.
• W4386838521 hasConceptScore W4386838521C195616568 @default.
• W4386838521 hasConceptScore W4386838521C203014093 @default.
• W4386838521 hasConceptScore W4386838521C22070199 @default.
• W4386838521 hasConceptScore W4386838521C2522874641 @default.
• W4386838521 hasConceptScore W4386838521C2776438120 @default.
• W4386838521 hasConceptScore W4386838521C2777474056 @default.
• W4386838521 hasConceptScore W4386838521C2778199166 @default.

• next